ABIGAIL POSNER: Open Payments
NPI 1609367804 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,571 in 375 payments from 25 companies in 2025. Trend: 2023 $1,572 · 2024 $4,436 · 2025 $5,571
Food & beverage: $5,410Education: $160
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 191 | $1,731 |
| ABBVIE INC. | 28 | $733 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 34 | $480 |
| Lilly USA, LLC | 24 | $428 |
| PFIZER INC. | 28 | $377 |
| Phathom Pharmaceuticals, Inc. | 7 | $373 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $361 |
| GENZYME CORPORATION | 8 | $196 |
| QOL Medical, LLC | 5 | $164 |
| Ardelyx, Inc. | 5 | $126 |
Products named: TREMFYA, VOQUEZNA, VELSIPITY, XIFAXAN, OMVOH, ENTYVIO, SKYRIZI, LINZESS.
Industry payments across NY — which companies pay providers there.
